首頁 > 市場調查報告書 > 工業機械

隔膜技術

市場調查報告書

商品編碼

1698393

製藥過濾市場：未來預測（2025-2030）

Pharmaceutical Filtration Market - Forecasts from 2025 to 2030

出版日期: 2025年02月27日 | 出版商:

Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球醫藥過濾市場預計將從 2025 年的 146.4 億美元成長到 2030 年的 212.4 億美元，複合年成長率為 8.50%。

全球範圍內炎症、感染和心血管疾病的發病率不斷上升，增加了對蛋白質類藥物的需求，預計這將在預測期內推動藥物過濾市場的成長。此外，越來越重視生技藥品用於開發治療各種疾病的治療方法也是推動整體市場成長的主要因素。

市場趨勢：

慢性病盛行率的不斷上升預計將推動對藥物過濾的需求。

推動醫藥過濾市場成長的主要因素是糖尿病、氣喘、癌症和自體免疫疾病等慢性疾病的盛行率不斷上升。慢性疾病患者不斷增加，推動了全球對先進治療藥物的需求。根據世界衛生組織 (WHO) 的數據，癌症是全球主要死亡原因之一，預計 2020 年將導致約 1,000 萬人死亡。

加大生技藥品研發投入

醫藥過濾市場的另一個關鍵驅動力是對生技藥品研發的投資不斷增加。單株抗體、重組 DNA (R-DNA) 技術、治療性蛋白質和疫苗等創新治療方法的採用正在刺激生物技術和製藥公司的成長。這些公司依賴膜、膠囊和濾芯等過濾技術。

製藥過濾市場：地理視角

預計預測期內北美和亞太地區將主導全球醫藥過濾市場。

從地理上看，製藥過濾市場分為北美、歐洲、亞太、南美和中東及非洲。由於生物製藥行業的不斷發展和製造設施的進步，北美預計將引領市場。同時，亞太地區預計將成為成長最快的市場，這得益於其龐大的慢性病人口以及中國和印度等國家疫苗產量的不斷增加。這些因素對全球醫藥過濾市場的擴張做出了重大貢獻。

報告中介紹的主要企業包括 3M、丹納赫集團、通用電氣醫療集團、GE 集團、Graver Technologies、默克密理博、派克漢尼汾集團、Repligen 公司、Sartorius Stedim Biotech 和賽默飛世爾科技。

本報告的主要優點

深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
適用範圍廣：對於新興企業、研究機構、顧問公司、中小企業和大型企業來說，它都是實用且具有成本效益的。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

製藥過濾市場細分

製藥過濾市場：按過濾類型細分

該報告根據過濾類型對市場進行細分，如下所示：
離心分離
重力型
真空型
其他

醫藥過濾市場依技術細分

該報告根據技術對市場進行如下細分：
交叉過濾
微過濾
超過濾
其他

製藥過濾市場：按應用細分

該報告按應用程式對市場進行細分如下：
水分離
原料過濾
產品過濾
其他

製藥過濾市場：按最終用戶產業細分

本報告按最終用戶產業分析市場如下：
製藥公司
生技公司
契約製造組織（CMO）
科學研究機構和大學
醫院和診所

製藥過濾市場：區域細分

該分析還提供了製藥過濾市場的特定國家/地區的預測和分析，將其分為以下區域：

北美（美國、加拿大、墨西哥）
南美洲（巴西、阿根廷等）
歐洲（德國、英國、法國、西班牙等）
中東和非洲（沙烏地阿拉伯、阿拉伯聯合大公國等）
亞太地區（中國、日本、印度、韓國、泰國、印尼、世界其他地區）。

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 其他
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 台灣
- 泰國
- 印尼
- 其他

第10章競爭格局及分析

主要企業和策略分析
市場佔有率分析
企業合併、協議、商業合作
競爭儀錶板

第11章公司簡介

3M
Danaher Corporation
GE Healthcare
GEA Group
Graver Technologies
Merck Millipore
Parker Hannifin Corporation
Repligen Corporation
Sartorius Stedim Biotech
Thermo Fisher Scientific

第12章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
分析方法
簡稱

簡介目錄

Product Code: KSI061610579

The global pharmaceutical filtration market is projected to grow at a CAGR of 8.50% to be worth US$21.24 billion in 2030 from US$14.64 billion in 2025.

Growing demand for protein-based drugs because of the rising prevalence of inflammatory, infectious, and cardiovascular diseases across the globe is expected to drive the pharmaceutical filtration market growth during the forecast period. Moreover, increasing emphasis on biologics for the development of treatment of various diseases is a major factor contributing to the overall market growth.

Market Trends:

The increasing prevalence of chronic diseases is expected to drive demand for pharmaceutical filtration.

A key factor supporting the growth of the pharmaceutical filtration market is the rising incidence of chronic conditions such as diabetes, asthma, cancer, and autoimmune diseases. The growing number of chronic disease cases has led to a higher demand for advanced therapeutic drugs worldwide. According to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 10 million deaths in 2020.

Increased investments in biologics R&D

Another significant driver of the pharmaceutical filtration market is the rising investment in the research and development of biologics. The adoption of innovative treatment therapies, such as monoclonal antibodies, recombinant DNA (R-DNA) technology, therapeutic proteins, and vaccines, has spurred growth in biotechnology and pharmaceutical companies. These companies rely on filtration techniques, including membranes, capsules, and cartridges, to support their operations.

Pharmaceutical Filtration Market Geographical Outlook:

North America and the Asia Pacific are expected to dominate the global pharmaceutical filtration market during the forecast period.

Geographically, the pharmaceutical filtration market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America is anticipated to lead the market, driven by the growing biopharmaceutical industry and advancements in manufacturing facilities. Meanwhile, the Asia Pacific region is projected to be the fastest-growing market, fueled by a large patient population with chronic diseases and increasing vaccine production in countries like China and India. These factors are significantly contributing to the expansion of the global pharmaceutical filtration market.

Some of the major players covered in this report include 3M, Danaher Corporation, GE Healthcare, GEA Group, Graver Technologies, Merck Millipore, Parker Hannifin Corporation, Repligen Corporation, Sartorius Stedim Biotech, Thermo Fisher Scientific among others.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Pharmaceutical Filtration Market Segmentations:

Pharmaceutical Filtration Market Segmentation by filtration type:

The market is analyzed by filtration type into the following:
Centrifugal
Gravity
Vacuum
Others

Pharmaceutical filtration market Segmentation by technology:

The report analyzes the market by technology as below:
Cross Filtration
Micro-Filtration
Ultra-Filtration
Others

Pharmaceutical filtration market Segmentation by application:

The market is analyzed by application into the following:
Water Separation
Raw Material Filtration
Product Filtration
Others

Pharmaceutical filtration market Segmentation by end-user segment:

The report analyzes the market by end-user segment as below:
Pharmaceutical Companies
Biotechnology Companies
Contract Manufacturing Organizations (CMOs)
Research Institutions & Universities
Hospitals and Clinics

Pharmaceutical filtration market Segmentation by regions:

The study also analyzed the pharmaceutical filtration market into the following regions, with country-level forecasts and analysis as below:

North America (US, Canada, and Mexico)
South America (Brazil, Argentina, and Others)
Europe (Germany, UK, France, Spain and Others
Middle East and Africa (Saudi Arabia, UAE and Others)
Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PHARMACEUTICAL FILTRATION MARKET BY FILTRATION TYPE

5.1. Introduction
5.2. Centrifugal
5.3. Gravity
5.4. Vacuum
5.5. Others

6. PHARMACEUTICAL FILTRATION MARKET BY TECHNOLOGY

6.1. Introduction
6.2. Cross Filtration
6.3. Micro-Filtration
6.4. Ultra-Filtration
6.5. Others

7. PHARMACEUTICAL FILTRATION MARKET BY APPLICATION

7.1. Introduction
7.2. Water Separation
7.3. Raw Material Filtration
7.4. Product Filtration
7.5. Others

8. PHARMACEUTICAL FILTRATION MARKET BY END-USER INDUSTRY

8.1. Introduction
8.2. Pharmaceutical Companies
8.3. Biotechnology Companies
8.4. Contract Manufacturing Organizations (CMOs)
8.5. Research Institutions & Universities
8.6. Hospitals and Clinics

9. PHARMACEUTICAL FILTRATION MARKET BY GEOGRAPHY

9.1. Introduction
9.2. North America
- 9.2.1. USA
- 9.2.2. Canada
- 9.2.3. Mexico
9.3. South America
- 9.3.1. Brazil
- 9.3.2. Argentina
- 9.3.3. Others
9.4. Europe
- 9.4.1. United Kingdom
- 9.4.2. Germany
- 9.4.3. France
- 9.4.4. Italy
- 9.4.5. Spain
- 9.4.6. Others
9.5. Middle East and Africa
- 9.5.1. Saudi Arabia
- 9.5.2. UAE
- 9.5.3. Others
9.6. Asia Pacific
- 9.6.1. China
- 9.6.2. Japan
- 9.6.3. India
- 9.6.4. South Korea
- 9.6.5. Taiwan
- 9.6.6. Thailand
- 9.6.7. Indonesia
- 9.6.8. Others